MKT Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-750
Closed -$233K 157
2026
Q1
$233K Sell
750
-858
-53% -$255K 0.08% 146
2025
Q4
$442K Hold
1,608
0.15% 89
2025
Q3
$427K Buy
1,608
+4
+0.2% +$1.09K 0.16% 89
2025
Q2
$442K Hold
1,604
0.17% 85
2025
Q1
$405K Hold
1,604
0.19% 77
2024
Q4
$373K Buy
1,604
+4
+0.3% +$920 0.16% 93
2024
Q3
$358K Sell
1,600
-9
-0.6% -$1.86K 0.17% 93
2024
Q2
$313K Sell
1,609
-19
-1% -$3.93K 0.16% 100
2024
Q1
$345K Sell
1,628
-1
-0.1% -$210 0.19% 98
2023
Q4
$324K Buy
1,629
+1
+0.1% +$213 0.21% 96
2023
Q3
$326K Buy
1,628
+19
+1% +$3.78K 0.25% 81
2023
Q2
$321K Sell
1,609
-17
-1% -$3.14K 0.23% 87
2023
Q1
$317K Buy
1,626
+17
+1% +$3.07K 0.24% 85
2022
Q4
$283K Sell
1,609
-29
-2% -$5.04K 0.21% 94
2022
Q3
$290K Sell
1,638
-6
-0.4% -$1.19K 0.25% 84
2022
Q2
$343K Sell
1,644
-15
-0.9% -$3.18K 0.27% 79
2022
Q1
$334K Buy
1,659
+8
+0.5% +$1.88K 0.25% 84
2021
Q4
$363K Buy
+1,651
New +$363K 0.28% 77

Other funds holding CME

MKT Advisors's CME Position: Q2 2026 in Review

MKT Advisors sold out of CME Group (CME) in Q2 2026, closing a stake of 750 shares — an estimated $233K sold.

MKT Advisors first reported a position in CME in Q4 2021 and held it in 18 quarters. The position peaked at $442K in Q4 2025. 352 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • MKT Advisors reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • MKT Advisors sold 750 CME Group shares in Q2 2026, an estimated $233K.
  • MKT Advisors first reported a position in CME Group in Q4 2021 and held it in 18 quarters.
  • MKT Advisors's CME Group position peaked at $442K in Q4 2025.
  • 352 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on MKT Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.